Literature DB >> 15568018

Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA.

Hoshang J Unwalla, Ming-Jie Li, James D Kim, Hai Tang Li, Ali Ehsani, Jessica Alluin, John J Rossi.   

Abstract

Here we demonstrate that an inducible anti-HIV short hairpin RNA (shRNA) expressed from a Pol II promoter inhibits HIV-1 gene expression in mammalian cells. Our strategy is based on a promoter system in which the HIV-1 LTR is fused to the Drosophila hsp70 minimal heat shock promoter. This system is inducible by HIV-1 TAT, which functions in a negative feedback loop to activate transcription of an shRNA directed against HIV-1 rev. Upon induction the shRNA is processed to an siRNA that guides inhibition of HIV replication in cultured T-lymphocytes and hematopoietic stem cell-derived monocytes. The fusion promoter system may be safer than drug-inducible systems for shRNA-mediated gene therapy against HIV as the shRNAs are only expressed following HIV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15568018     DOI: 10.1038/nbt1040

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  39 in total

1.  Characterization of an HIV-targeted transcriptional gene-silencing RNA in primary cells.

Authors:  Anne-Marie W Turner; Amanda M Ackley; Michael A Matrone; Kevin V Morris
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

2.  The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells.

Authors:  Marc S Weinberg; Louisa M Villeneuve; Ali Ehsani; Mohammed Amarzguioui; Lars Aagaard; Zhao-Xia Chen; Arthur D Riggs; John J Rossi; Kevin V Morris
Journal:  RNA       Date:  2005-12-22       Impact factor: 4.942

3.  Novel Pol II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein.

Authors:  Hoshang J Unwalla; Hai-Tang Li; Ingrid Bahner; Ming-Jie Li; Donald Kohn; John J Rossi
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Tat-regulated expression of RNA interference: triggers for the treatment of HIV infection.

Authors:  Hoshang Unwalla; John J Rossi
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.071

5.  Use of a U16 snoRNA-containing ribozyme library to identify ribozyme targets in HIV-1.

Authors:  Hoshang J Unwalla; Haitang Li; Shi-Yang Li; Danny Abad; John J Rossi
Journal:  Mol Ther       Date:  2008-04-01       Impact factor: 11.454

6.  Inhibition of HIV-1 by a Lentiviral Vector with a Novel Tat-Inducible Expression System and a Specific Tropism to the Target Cells.

Authors:  Touraj Farazmandfar; Mohammad Reza Haghshenas; Majid Shahbazi
Journal:  Hum Gene Ther       Date:  2015-08-06       Impact factor: 5.695

Review 7.  Aptamers in HIV research diagnosis and therapy.

Authors:  Jyoti Bala; Srinivasan Chinnapaiyan; Rajib Kumar Dutta; Hoshang Unwalla
Journal:  RNA Biol       Date:  2018-02-12       Impact factor: 4.652

Review 8.  RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?

Authors:  Sandesh Subramanya; Sang-Soo Kim; N Manjunath; Premlata Shankar
Journal:  Expert Opin Biol Ther       Date:  2010-02       Impact factor: 4.388

9.  A dual function TAR Decoy serves as an anti-HIV siRNA delivery vehicle.

Authors:  Hoshang J Unwalla; John J Rossi
Journal:  Virol J       Date:  2010-02-10       Impact factor: 4.099

10.  A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs.

Authors:  Olivier ter Brake; Ben Berkhout
Journal:  J RNAi Gene Silencing       Date:  2005-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.